Concepedia

Zhenfan Yang

ZY

31

Publications

2.7K

Citations

24

H-Index

2000

Active since

Affiliations

Shanghai Innovative Research Center of Traditional Chinese Medicine(Current)

Seoul National University Hospital

Samsung Medical Center

National Taiwan University Hospital

AstraZeneca (United Kingdom)

Zhenfan Yang is an author at Shanghai Innovative Research Center of Traditional Chinese Medicine specializing in medicine, pathology, and oncology.

Top concepts

Publications per year

2000–2023

31

Publications

31

Preclinical Comparison of Osimertinib with Other EGFR-TKIs in EGFR-Mutant NSCLC Brain Metastases Models, and Early Evidence of Clinical Brain Metastases Activity

Peter Ballard, James Yates, Zhenfan Yang et al. · Clinical Cancer Research · 2016 · 704 citations

The brain-penetrant clinical ATM inhibitor AZD1390 radiosensitizes and improves survival of preclinical brain tumor models

Stephen T. Durant, Li Zheng, Yingchun Wang et al. · Science Advances · 2018 · 292 citations · Full text

Tumor Microvessel Density as a Predictor of Recurrence After Resection of Hepatocellular Carcinoma: A Prospective Study

Ronnie Tung‐Ping Poon, Irene Oi‐Lin Ng, Cecilia Lau et al. · Journal of Clinical Oncology · 2002 · 284 citations

Activity and safety of AZD3759 in EGFR-mutant non-small-cell lung cancer with CNS metastases (BLOOM): a phase 1, open-label, dose-escalation and dose-expansion study

Myung‐Ju Ahn, Dong‐Wan Kim, Byoung Chul Cho et al. · The Lancet Respiratory Medicine · 2017 · 108 citations · Full text

, , +9

EGFR G796D mutation mediates resistance to osimertinib

Di Zheng, Min Hu, Yu Bai et al. · Oncotarget · 2017 · 104 citations · Full text

Rows per page

1–5 of 31